Literature DB >> 9316858

Selectivity in the generalization profile in baboons trained to discriminate lorazepam: benzodiazepines, barbiturates and other sedative/anxiolytics.

N A Ator1, R R Griffiths.   

Abstract

The discriminative stimulus effects of benzodiazepines often have been indistinguishable from those of barbiturates or other sedative/anxiolytics. However, baboons and rats trained to discriminate lorazepam did not reliably generalize to pentobarbital in previous studies, although animals comparably trained to discriminate pentobarbital reliably generalized to lorazepam. The present study investigated the generalization profile for a variety of anxiolytic, sedative and other drugs in baboons trained to discriminate oral lorazepam (1.8 mg/kg). Triazolam, alprazolam, diazepam, midazolam, bromazepam, temazepam and nordiazepam occasioned >80% of total responses on the lorazepam-paired lever, in that order of potency, 60 min after oral dosing; chlordiazepoxide did so in three of five baboons. However, barbiturates (amobarbital, hexobarbital, methohexital, pentobarbital, phenobarbital, secobarbital) and methypryIon occasioned lorazepam-appropriate responding in only one or two baboons. Testing barbiturates at different pretreatment times (amobarbital, hexobarbital, pentobarbital or secobarbital) or by an i.m. route of administration (methohexital, pentobarbital) did not produce an increase in generalization. Neither other classic sedatives/anxiolytics (chloral hydrate, clomethiazole, ethanol, methaqualone, meprobamate, triclofos), nor anticonvulsants (phenytoin, valproic acid), nor drugs from other pharmacological classes shared discriminative-stimulus effects with lorazepam. These results, together with those from previous studies in which lorazepam or another benzodiazepine served as the training stimulus, indicate that lorazepam training results in a more selective generalization profile with respect to sedative/anxiolytic drugs than does training with other benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9316858

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Lorazepam should no longer be used as a prototypical benzodiazepine.

Authors:  S Pompéia; O F A Bueno; S Tufik
Journal:  Psychopharmacology (Berl)       Date:  2003-05-28       Impact factor: 4.530

2.  What makes lorazepam different from other benzodiazepines?

Authors:  S Pompéia; G M Manzano; S Tufik; O F A Bueno
Journal:  J Physiol       Date:  2005-12-01       Impact factor: 5.182

Review 3.  Cross-Species Translational Findings in the Discriminative Stimulus Effects of Ethanol.

Authors:  Daicia C Allen; Matthew M Ford; Kathleen A Grant
Journal:  Curr Top Behav Neurosci       Date:  2018

4.  GABAA-positive modulator selective discriminative stimulus effects of 1,1,1-trichloroethane vapor.

Authors:  Keith L Shelton; Katherine L Nicholson
Journal:  Drug Alcohol Depend       Date:  2011-09-15       Impact factor: 4.492

5.  GABA(A) positive modulator and NMDA antagonist-like discriminative stimulus effects of isoflurane vapor in mice.

Authors:  Keith L Shelton; Katherine L Nicholson
Journal:  Psychopharmacology (Berl)       Date:  2010-08-10       Impact factor: 4.530

6.  Changes in relative potency among positive GABA(A) receptor modulators upon discontinuation of chronic benzodiazepine treatment in rhesus monkeys.

Authors:  Lance R McMahon; Martin A Javors; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2007-01-24       Impact factor: 4.415

7.  Drug-Biopolymer Dispersions: Morphology- and Temperature- Dependent (Anti)Plasticizer Effect of the Drug and Component-Specific Johari-Goldstein Relaxations.

Authors:  Sofia Valenti; Luis Javier Del Valle; Michela Romanini; Meritxell Mitjana; Jordi Puiggalí; Josep Lluís Tamarit; Roberto Macovez
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.